Tumor efficacy

Subcutaneous Tumor Xenografts: Cell-Derived Xenograft (CDX) Models, Patient-Derived Xenograft (PDX) Models of Human Tumors In situ tumor transplantation models (e.g., brain, lung, liver, ascitic tumors) equipped with in vivo imaging detection capabilities. Tumor immunotherapy mouse models: immune-reconstituted mouse tumor models, syngeneic transplant mouse models, genetically engineered humanized models (GEMMs), and in vitro assays (cell uptake; cytotoxicity, apoptosis, necrosis; cell invasion, metastasis, etc.).

Tumor efficacy

Subcutaneous tumor graft: Cell-derived xenograft (CDX) models, patient-derived xenograft (PDX) models of human tumor tissues

In situ tumor transplantation model: (Cerebral, pulmonary, hepatic, ascitic tumors, etc.) equipped with in vivo imaging detection capabilities.

Tumor immunotherapy mouse model: Immune-reconstituted mouse tumor models, syngeneic transplant mouse models, genetically engineered humanized models (GEMMs), and in vitro assays (cell uptake; cytotoxicity, apoptosis, necrosis; cell invasion, metastasis, etc.)